Evidence map›Paper›PMID 37322365›Full record

ArticleNature cancer2023

Ricolinostat is not a highly selective HDAC6 inhibitor.

Guillaume Médard, Jason M Sheltzer

Abstract readLetterComment
PubMed Publisher
In one paragraph

Article in Nature cancer, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

Guillaume MédardProteomics Core Facility, Department of Chemistry, National and Kapodistrian University of Athens, Athens, Greece.ORCID http://orcid.org/0000-0002-4782-4029
Jason M SheltzerYale University School of Medicine, New Haven, CT, USA. jason.sheltzer@yale.edu.ORCID http://orcid.org/0000-0003-1381-1323
National and Kapodistrian University of Athens · GRYale University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Hydroxamic AcidsPyrimidinesHydroxamic AcidsPyrimidinesricolinostat

Identifiers

PMID37322365
OpenAlexW4380714900

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.